3SBio, Panacor Bioscience enter pact to develop & commercialize Nephoxil for hyperphosphatemia
Wednesday, February 10, 2010 15:00 IST Shenyang, China
3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, announced a collaboration and license agreement
